They can make or break your experience, and your doctor might not have mentioned them.

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...

A major new study finds the pace of biological discovery is accelerating, not slowing down, and estimates Earth may harbor ...

If the rest of 2026 continues in this vein, we may look back on January and February as the moment the sector recognised that ...

Bollywood producer Ektaa Kapoor had a first-time experience recently as she watched an entire cricket match: the ICC Men's ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Q: I’m taking a GLP-1 to help me control my blood sugar and lose weight. But the cost and side effects of having to do resistance exercise make it difficult ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

A recent survey carried out by trade show IFE finds that cost remains a central concern when it comes to encouraging consumers to make healthier choices. More than half of food and drink leaders ...